Emend
Product Images NDC 42254-160

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Emend (NDC 42254-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Chemical Structure (Ec44482e 6194 4829 A3f7 Ebe8d48a41a5 01)

Chemical structure of the active ingredient in EMEND, showing multiple ring systems including a purine-like moiety, a morpholine ring, and a fluorinated aromatic ring, along with trifluoromethyl substituents on a benzene ring.*

FDA Label Image

Image Of Figure 1 (Ec44482e 6194 4829 A3f7 Ebe8d48a41a5 02)

Two line graphs labeled Study 1 and Study 2 showing the percent of patients over time in hours up to 120 for EMEND (aprepitant regimen) compared to standard therapy. Both graphs show higher patient percentages for the aprepitant regimen than for standard therapy, indicating better patient outcomes over time.*

FDA Label Image

Image Of Figure 2 (Ec44482e 6194 4829 A3f7 Ebe8d48a41a5 03)

This figure presents two bar charts labeled Study 1 and Study 2, each showing the percent of patients over chemotherapy cycles 2 through 6. The charts compare the Aprepitant Regimen versus Standard Therapy groups across different cycles, with corresponding patient counts noted below each cycle.*

FDA Label Image

Image Of Figure 3 (Ec44482e 6194 4829 A3f7 Ebe8d48a41a5 04)

A line graph comparing the percent of patients over time (hours) receiving Aprepitant 40 mg versus Ondansetron. The x-axis is labeled in hours from 0 to 48, and the y-axis shows percent of patients from 0 to 100%. The graph illustrates a higher percent of patients maintained over time with Aprepitant 40 mg compared to Ondansetron.*

FDA Label Image

Emend 40mg (Ec44482e 6194 4829 A3f7 Ebe8d48a41a5 05)

The label is for EMEND 40mg capsules, NDC 42254-160-01, distributed by Physician Partner, a division of Rebel Distributors Corp. It specifies each capsule contains 40mg Aprepitant in an opaque hard gelatin capsule with a white body and mustard yellow cap, marked with '464' and '40mg' in black ink. The label includes storage temperature instructions and a Product ID SE016001.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.